drugset / Press release
FDA Accepts Emergent BioSolutions’ Supplemental Biologics License Application for Large-Scale Manufacturing of BioThrax in Building 55
2016-06-17 · Emergent BioSolutions · original emergentbiosolutions.com ↗
061716 - FDA Accepts sBLA for B55 FINAL.pdf 75.7 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗